Skip to main content
. 2015 May 27;89(16):8130–8151. doi: 10.1128/JVI.01221-14

TABLE 2.

Description of reagents used to characterize the SIVsm Env panela

Reagent Target Provider Catalog no. Source Reference(s)
Rhesus anti-HIV-2 MAb 3.11H V3 James E. Robinson SIV/17E-CL-infected RM at ∼12 mo 17, 49
Human anti-HIV-2 MAb 6.10B CD4bs James E. Robinson HIV-2-infected Gambian subject N37126 17, 4953
Human anti-HIV-2 MAb 1.4H CD4i James E. Robinson HIV-2-infected Gambian subject N37126 17, 4953
Mouse anti-SIVmac251 MAb gp120 Advanced Bioscience Laboratories, Inc. 4327
AMD-3100 (JM-2987) CXCR4 AIDS Reagent Program 8128 5456
Maraviroc (Selzentry) CCR5 AIDS Reagent Program 11580 57, 58
Recombinant human sCD4 CD4bs AIDS Reagent Program/Progenics 4615
T1249 gp41 HR1 Trimeris 59
SIVmac239-infected RM plasma pool Polyclonal Francois Villinger, Yerkes 20 rhesus macaques ∼33 wk after SIV infection
SIVmac251-infected RM plasma pool 1 Polyclonal Rama R. Amara, Yerkes 15 RMs ∼16 wk after SIV infection
SIV-infected SM pool Polyclonal Francois Villinger, Yerkes 29 naturally SIV-infected SMs
SIVmac251-infected serum pool 2 Polyclonal AIDS Reagent Program 2773 6 SIV-infected RMs 60
Normal RM serum pool NA Yerkes 8 uninfected, unvaccinated RMs
a

SM, sooty mangabey; RM, rhesus macaque; NA, not available.